Issam I Raad (Issam Raad)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 11

Top Topics

Multidrug Resistant

Coronavirus Disease

Chemotherapy Induced

Top Venues

JAC-antimicrobial resistance

Open forum infectious diseases

Infection control and hospital epidemiology

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Bahgat Z Gerges, Joel Rosenblatt, Y-Lan Truong, Ying Jiang, Samuel A Shelburne Iii, Anne-Marie Chaftari, Ray Hachem, Issam I Raad
In vitro activity of cefepime/taniborbactam and comparator agents against Gram-negative bacterial bloodstream pathogens recovered from patients with cancer. JAC-antimicrobial resistance 6 (2) (2024)
Anne-Marie Chaftari, Hiba Dagher, Ray Hachem, Ying Jiang, Peter Lamie, Rita Wilson Dib, Teny M John, Andrea Haddad, Ann Philip, Shahnoor Alii, Patricia Mulanovich, Ying Yuan, Patrick Chaftari, Issam I Raad
A randomized non-inferiority study comparing imipenem/cilastatin/relebactam with standard-of-care Gram-negative coverage in cancer patients with febrile neutropenia. The Journal of antimicrobial chemotherapy (2024)
Bahgat Z Gerges, Joel Rosenblatt, Y-Lan Truong, Ying Jiang, Samuel A Shelburne Iii, Anne-Marie Chaftari, Ray Hachem, Issam I Raad
In vitro activity of cefepime/taniborbactam and comparator agents against Gram-negative bacterial bloodstream pathogens recovered from patients with cancer. JAC-antimicrobial resistance 6 (2) (2024)
Bahgat Z Gerges, Joel Rosenblatt, Y-Lan Truong, Ying Jiang, Samuel A Shelburne Iii, Anne-Marie Chaftari, Ray Hachem, Issam I Raad
In vitro activity of cefepime/taniborbactam and comparator agents against Gram-negative bacterial bloodstream pathogens recovered from patients with cancer. JAC-antimicrobial resistance 6 (2) (2024)
Kenneth Rolston, Bahgat Gerges, Lior Nesher, Samuel A Shelburne Iii, Randall Prince, Issam I Raad
In vitro activity of eravacycline and comparator agents against bacterial pathogens isolated from patients with cancer. JAC-antimicrobial resistance 5 (2) (2023)
Bahgat Z Gerges, Joel Rosenblatt, Samuel A Shelburne Iii, Anne-Marie Chaftari, Ray Hachem, Issam I Raad
In vitro activity of tebipenem and comparator agents against bacterial pathogens isolated from patients with cancer. JAC-antimicrobial resistance 5 (6) (2023)
Kenneth Rolston, Bahgat Gerges, Lior Nesher, Samuel A Shelburne Iii, Randall Prince, Issam I Raad
In vitro activity of eravacycline and comparator agents against bacterial pathogens isolated from patients with cancer. JAC-antimicrobial resistance 5 (2) (2023)
Anne-Marie Chaftari, Ray Hachem, Alexandre E Malek, Victor E Mulanovich, Ariel D Szvalb, Ying Jiang, Ying Yuan, Shahnoor Ali, Rita Deeba, Patrick Chaftari, Issam I Raad
A Prospective Randomized Study Comparing Ceftolozane/Tazobactam to Standard of Care in the Management of Neutropenia and Fever in Patients With Hematological Malignancies. Open forum infectious diseases 9 (6) (2022)
Bahgat Z Gerges, Joel Rosenblatt, Y-Lan Truong, Ruth A Reitzel, Ray Y Hachem, Issam I Raad
Enhanced Biofilm Eradication and Reduced Cytotoxicity of a Novel Polygalacturonic and Caprylic Acid Wound Ointment Compared with Common Antiseptic Ointments. BioMed research international 2021 (2021)
Melissa Khalil, Kaveh Karimzad, Jean-Bernard Durand, Alexandre E Malek, Issam I Raad, George M Viola
Prevention of Cardiac Implantable Electronic Device-Related Infection in Patients With Cancer: The Role of a Comprehensive Prophylactic Bundle Approach That Includes the Antimicrobial Mesh. Open forum infectious diseases 7 (11) (2020)
Ella J Ariza-Heredia, Elizabeth Frenzel, Sherry Cantu, Mary Carlson, Georgia Thomas, Fareed Khawaja, Issam I Raad, Roy F Chemaly
Surveillance and identification of clusters of healthcare workers with coronavirus disease 2019 (COVID-19): Multidimensional interventions at a comprehensive cancer center. Infection control and hospital epidemiology 42 (7) (2020)